Filing Details

Accession Number:
0001640334-20-002027
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-11 14:53:08
Reporting Period:
2020-08-07
Accepted Time:
2020-08-11 14:53:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1516551 Emerald Bioscience Inc. EMBI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1425052 Punit Dhillon 5910 Pacific Center Blvd
Suite 320
San Diego CA 92121
Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-07 1,000,000 $100,000.00 1,000,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Option Grant (Right to Buy) Acquisiton 2020-08-07 9,000,000 $0.00 9,000,000 $0.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
9,200,000 2030-08-07 No 4 A Direct
Footnotes
  1. Private purchase transaction from Emerald Health Sciences at $0.10 per share.
  2. Each of the Options shall be exercisable for a price of $0.045 per Option Share for ten years from August 7, 2020 (the "Grant Date") and allOptions will vest 10% on the Grant Date and 90% in equal semiannual installments over four and a half years.